TPC
JBIO

Takeda Pharmaceutical Company’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History

Takeda Pharmaceutical Company’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-388
Closed -$402K – 14
2024
Q1 		$402K Hold
388
– – 0.14% 13
2023
Q4 		$307K Buy
+388
New +$307K 0.09% 13